Background and activities

MD, internal medicine specialist. Consultant at Clinic of Cardiology, St. Olavs University Hospital. PhD-candidate at Department of Circulation and Medical Imaging, Faculty of Medicine, NTNU.

Clinical interests are general cardiology, invasive cardiology and coronary heart disease. Research field is coronary heart disease and inflammation. We study the effects of interleukin-6 (IL-6) blockade with the IL-6 receptor antagonist tocilizumab in acute coronary heart disease. We investigate the effects of tocilizumab on inflammation and myocardial damage/ischemia-reperfusion injury in myocardial infarction.

Scientific, academic and artistic work

Displaying a selection of activities. See all publications in the database

Journal publications


  • Kleveland, Ola; Kunszt, Gabor; Bratlie, Marte; Ueland, Thor; Amundsen, Brage H.; Aakhus, Svend; Damås, Jan Kristian; Aukrust, Pål; Wiseth, Rune; Gullestad, Lars. (2015) The interleukin-6 receptor antagonist tocilizumab reduces inflammation and myocardial damage in non-ST elevation myocardial infarction - a randomized, double-blind, placebo controlled study. ESC Congress 2015 . European Society of Cardiology; London. 2015-08-29 - 2015-09-02.